← Back to PROF

Profound Medical Corp. - common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
$2.5$5.3$5.1$2$2.3$2.5$2$1.2
−$9.5−$7.1−$8−$16−$11−$9.4−$6.9−$6.6
−$0.26$0.19$0.26−$0.52$0.36$0.38$0.28$0.27
3636303030252424

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.